Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NRX Pharmaceuticals ( (NRXP) ) has provided an update.
On January 7, 2025, Janet Rehnquist resigned from the Board of Directors of NRx Pharmaceuticals, effective immediately, without any disagreements with the company’s operations, policies, or practices. Her resignation follows the approval of a term sheet with JGS Holdings LLC, granting Sauer Nunes the right to nominate a new board member, with management currently reviewing nominees.
More about NRX Pharmaceuticals
YTD Price Performance: 64.21%
Average Trading Volume: 1,006,308
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $58.66M
See more data about NRXP stock on TipRanks’ Stock Analysis page.
